FREQUENT BASELINE EGFR MUTATION T790M IN CYTOLOGICAL SPECIMENS OF TYROSINE KINASE INHIBITOR (TKI) NAIVE ADENOCARCINOMA NSCLC PATIENTS

被引：0

作者：

Andarini, S. L. ^{[1
]}

Zaini, J. ^{[1
]}

Hudoyo, A. ^{[1
]}

Hidayat, H. ^{[1
]}

Widjajahakim, G. ^{[2
]}

Utomo, A. R. ^{[3
]}

机构：

[1] Univ Indonesia, Persahabatan Hosp, Dept Pulmonol & Resp Med, Fac Med, Jakarta, Indonesia

[2] KalGen Lab, Pathol Core Facil, Jakarta, Indonesia

[3] KalGen Lab, Stem Cell & Canc Inst, Canc Diagnost Res, Jakarta, Indonesia

来源：

RESPIROLOGY | 2016年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

APSR6-0587

引用

页码：79 / 79

页数：1

共 50 条

[41] Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation
Luo, Yung-Hung
Liu, Han
Wampfler, Jason A.
Tazelaar, Henry D.
Li, Yalun
Peikert, Tobias
Liu, Dan
Leventakos, Konstantinos
Chen, Yuh-Min
Yang, Yanan
Chiou, Shih-Hwa
Yang, Ping
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (08) : 2099 - 2114
[42] Frequency and abundance of plasma T790M mutation associated with failure patterns of EGFR-mutant NSCLC treated with tyrosine kinase inhibitors
Zhang, S.
Zhu, L.
Xia, B.
Chen, E.
Zhao, Q.
Chen, X.
Wang, L.
Jiang, H.
Ma, S.
ANNALS OF ONCOLOGY, 2016, 27
[43] Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment
Passaro, Antonio
Guerini-Rocco, Elena
Pochesci, Alessia
Vacirca, Davide
Spitaleri, Gianluca
Catania, Chiara Matilde
Rappa, Alessandra
Barberis, Massimo
de Marinis, Filippo
PHARMACOLOGICAL RESEARCH, 2017, 117 : 406 - 415
[44] Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation
Yung-Hung Luo
Han Liu
Jason A. Wampfler
Henry D. Tazelaar
Yalun Li
Tobias Peikert
Dan Liu
Konstantinos Leventakos
Yuh-Min Chen
Yanan Yang
Shih-Hwa Chiou
Ping Yang
Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2099 - 2114
[45] Dynamics of Plasma EGFR T790M Mutation in Advanced NSCLC: A Multicenter Study
Zhengquan Yang
Jialu Li
Yujie Hu
Meihua Chen
Danli Peng
Dan Zong
Qingjuan Shang
Lianqin Tao
Yanling Zhao
Yiyun Ni
Jinyan Ye
Yupeng Xie
Li Yang
Quan Lin
Chang Cai
Ning Xu
Xiaoping Huang
Xiaoting Dong
Zhonghui Zhou
Yali Yu
Zongxiao Shangguan
Yangyang Xu
Weiping Ying
Meiling Weng
Zuguo Yuan
Zhijun Dong
Jifa Li
Zhe Zheng
Jiongwei Pan
Lu Liu
Junhui Ye
Zhan Zhang
Wenfeng Li
Junfei Zhu
Shengnan Jin
Yuping Li
Chunming Ding
Targeted Oncology, 2019, 14 : 719 - 728
[46] Predictive factors and prognostic significance of T790M mutation in patients with EGFR-mutant NSCLC
Hwang, Ji An
Choi, Chang-Min
Lee, Jae Cheol
EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[47] Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients
Kuiper, J. L.
Heideman, D. A. M.
Thunnissen, E.
Paul, M. A.
van Wijk, A. W.
Postmus, P. E.
Smit, E. F.
LUNG CANCER, 2014, 85 (01) : 19 - 24
[48] Dynamic mutation profiles of Chinese patients with EGFR T790M advanced NSCLC receiving osimertinib
Zhang, X.
Wu, Y-L.
Chen, Y.
Zhang, H.
Wu, G.
Lu, Y.
Liang, Z.
Hu, Y.
Cheng, Y.
Wang, J.
Ying, J.
Liu, W.
Liang, Z.
ANNALS OF ONCOLOGY, 2022, 33 : S1537 - S1537
[49] Detection of EGFR T790M mutation by ddPCR in untreated NSCLC patients: Correlation with clinical outcome
Ganzinelli, Monica
Rulli, Eliana
Tamborini, Elena
Busico, Adele
Lo Russo, Giuseppe
Corrao, Giulia
Vitali, Milena
Garassino, Marina Chiara
Broggini, Massimo
Marabese, Mirko
CANCER RESEARCH, 2017, 77
[50] The Clinical Usefulness of Liquid Biopsy for Detection and Dynamic Monitoring of EGFR T790M in NSCLC Patients on EGFR-TKI Therapy
Szpechcinski, A.
Duk, K.
Bryl, M.
Czyzewicz, G.
Wojda, E.
Florczuk, M.
Sliwinski, P.
Barinow-Wojewodzki, A.
Chorostowska-Wynimko, J.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S803 - S803

← 1 2 3 4 5 →